BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16416183)

  • 1. Pancreatic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Drygiannakis D; Karmiris K; Drygiannakis I; Makreas S; Kouroumalis EA
    Dig Dis Sci; 2005 Dec; 50(12):2330-4. PubMed ID: 16416183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic autoantibodies in inflammatory bowel disease.
    Joossens S; Vermeire S; Van Steen K; Godefridis G; Claessens G; Pierik M; Vlietinck R; Aerts R; Rutgeerts P; Bossuyt X
    Inflamm Bowel Dis; 2004 Nov; 10(6):771-7. PubMed ID: 15626896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
    Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
    Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
    Papp M; Sipeki N; Tornai T; Altorjay I; Norman GL; Shums Z; Roggenbuck D; Fechner K; Stöcker W; Antal-Szalmas P; Veres G; Lakatos PL
    J Crohns Colitis; 2015 Aug; 9(8):659-68. PubMed ID: 25968583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives.
    Demirsoy H; Ozdil K; Ersoy O; Kesici B; Karaca C; Alkim C; Akbayir N; Erdem LK; Onuk MD; Beyzadeoglu HT
    World J Gastroenterol; 2010 Dec; 16(45):5732-8. PubMed ID: 21128324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
    Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
    Halme L; Turunen U; Heliö T; Paavola P; Walle T; Miettinen A; Järvinen H; Kontula K; Färkkilä M
    Scand J Gastroenterol; 2002 Jun; 37(6):692-8. PubMed ID: 12126248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic epidemiology of inflammatory bowel disease in Puerto Rico.
    Appleyard CB; Hernández G; Rios-Bedoya CF
    Inflamm Bowel Dis; 2004 Mar; 10(2):106-11. PubMed ID: 15168809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
    Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A
    Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases.
    Farkona S; Soosaipillai A; Filippou P; Liaskos C; Bogdanos DP; Diamandis EP; Blasutig IM
    Clin Chem Lab Med; 2017 Aug; 55(10):1574-1581. PubMed ID: 28343172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.
    Kovacs M; Lakatos PL; Papp M; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Muller KE; Molnar K; Szabo D; Cseh A; Dezsofi A; Arato A; Veres G
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):429-35. PubMed ID: 22465933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
    Janssen KMJ; Hop H; Vissink A; Dijkstra G; de Smit MJ; Brouwer E; Westra J
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data.
    Nerich V; Monnet E; Etienne A; Louafi S; Ramée C; Rican S; Weill A; Vallier N; Vanbockstael V; Auleley GR; Allemand H; Carbonnel F
    Inflamm Bowel Dis; 2006 Mar; 12(3):218-26. PubMed ID: 16534424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.
    Michaels MA; Jendrek ST; Korf T; Nitzsche T; Teegen B; Komorowski L; Derer S; Schröder T; Baer F; Lehnert H; Büning J; Fellerman K; Sina C
    Inflamm Bowel Dis; 2015 Dec; 21(12):2864-72. PubMed ID: 26273818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.